Pancreatitis : Pancreatitis has been reported for some patients taking these medications
The lateral parabrachial nucleus may be a critical site of action as pharmacological activation of GLP-Rs in the lateral parabrachial nucleus (LPBN) inhibits feeding whereas antagonism of LPBN GLP-1Rs induces hyperphagia (Alhadeff et al., 2014)
GLP-1R agonists improve glucose homeostasis in patients with T2DM, cause weight loss, and benefit cardiovascular health over time
In conclusion, the targeted molecular pathways, including Phospholipids and Lysophospholipids metabolism, Purine metabolism, NAD metabolism, and Insulin resistance-related metabolism, may be involved in the renal protective effects of semaglutide
The primary measures used to evaluate the drugs effects were changes in the patients scores on the Unified Parkinson Disease Rating Scale (UPDRS), which measures their ability to perform daily activities and motor function